Therapeutic Asset Ratings
2,273 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FILGRASTIM
Prolymphocytic Leukemia
Center for International Blood and Marrow Transplant Research
P2
BB
(67)
FILGRASTIM
Severe Combined Immunodeficiency
National Institute of Allergy and Infectious Diseases (NIAID)
P2
BB
(67)
FILGRASTIM
Stage IV Pancreatic Cancer
General Oncology, Inc.
P2
BB
(67)
PEGFILGRASTIM
Marginal Zone Lymphoma
Mayo Clinic
P2
BB
(67)
(1-743)-(1638-2332)-BLOOD-COAGULATION FACTOR VIII (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT), (1444-6'),(1447-9')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT)
Hemophilia A
Margaret Ragni
P4
BB
(66)
CYCLOSPORIN A
Insulin
Barbara Burgos Blasco
P4
BB
(66)
DULAGLUTIDE
Type 2 Diabetes Mellitus
Brigham and Women's Hospital
P4
BB
(66)
FILGRASTIM
Acute Lymphoblastic Leukemia
Guenther Koehne
P4
BB
(66)
FILGRASTIM
High Risk
The First Affiliated Hospital of Soochow University
P4
BB
(66)
Genotropin
Prediabetes Syndrome
Columbia University
P4
BB
(66)
Glucagon
Type 2 Diabetes Mellitus
Rutgers, The State University of New Jersey
P4
BB
(66)
INSULIN GLARGINE (SANOFI)
Diabetes Mellitus, Type 2
Eli Lilly and Company
P4
BB
(66)
Oxytocin
Obesity Disorder
University Hospital, Gentofte, Copenhagen
P4
BB
(66)
Oxytocin
Schizophrenia
Charite University, Berlin, Germany
P4
BB
(66)
ASPARAGINASE
Down Syndrome
National Hospital Organization Nagoya Medical Center
P3
BB
(66)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
B Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
BB
(66)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
Down Syndrome
National Cancer Institute (NCI)
P3
BB
(66)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
T-Cell Acute Lymphoblastic Leukemia
University of Washington
P3
BB
(66)
Calaspargase Pegol
Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
P3
BB
(66)
Cipaglucosidase Alfa-ATGA
Glycogen Storage Disease Due To Acid Maltase Deficiency, Late-Onset
Amicus Therapeutics
P3
BB
(66)
CYCLOSPORIN A
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P3
BB
(66)
CYCLOSPORIN A
Hematopoietic And Lymphoid Cell Neoplasm
Children's Oncology Group
P3
BB
(66)
FILGRASTIM
Hodgkins Lymphoma
Thomas Jefferson University
P3
BB
(66)
human hyaluronidase isozyme-5 (HYAL5, sperm adhesion molecule 1, SPAM1, hyaluronidase PH-20, EC:3.2.1.35) fragment (3-433, 1-431 in the current sequence) engineered variant with the structural domain replaced by the corresponding region of human hyaluronidase isozyme-1 (HYAL1)(<sup>306</sup>TLSIMRSMKSCLLDDNYMETI<sup>326</sup>><sup>304</sup>SWENTRTKESCQAIKEYMDTT<sup>324</sup>), produced in Chinese hamster ovary (CHO) cells, cell line DG44, glycoform alfa
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC
P3
BB
(66)
INTERFERON ALFA-2B
Metastatic Melanoma
National Cancer Institute (NCI)
P3
BB
(66)
Showing 301 to 325 of 2,273 assets
Previous
Page 13 of 91
Next